NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Norsa Pharma

Norsa Pharma

Private
PolandHealthcare & Life Scienceshttps://norsapharma.com/sklep/

Last Round

Grant

Apr 16, 2018

Total Funding Raised

$500,000

Company Overview

Norsa Pharma is a Polish pharmaceutical and nutraceutical company that develops and manufactures specialized dietary supplements and medical nutrition products for patients with metabolic, autoimmune, and other specific health conditions.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, D2C Brands, Precision Medicine, E-commerce

Business Model

B2C

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

nutraceuticalsdietary supplementsmedical nutritionsupplementsprecision medicinebioavailabilityclean-labelmetabolic supportgut healththyroid supportDTCdirect-to-consumerprobiotic supplementomega-3biohacking

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Norsa Pharma Comparables

Compare Norsa Pharma with similar companies based on industry and business-model similarity.

Norsa Pharma comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Seeking Health
72%
Nestlé
72%
Pharma Nord
69%

Norsa Pharma Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantApr 16, 2018

Key People

Founding team and executive leadership

Mateusz Data

CEO Co-Founder

Founding Team

Norsa Pharma Investors

Notable investors and investment history

Norsa Pharma investors
InvestorRounds
European Regional Development FundGrant
Meta VenturesSeed
Aper VenturesSeed

Norsa Pharma Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Norsa Pharma Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Norsa Pharma's valuation, stock price, and market status.

Firmographic Details

HeadquartersPoland
Employee Range4
Year Founded2015
Last FundingApr 16, 2018

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.